127 related articles for article (PubMed ID: 6159323)
21. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
[TBL] [Abstract][Full Text] [Related]
22. Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition.
Mishler JM; Ricketts CR; Parkhouse EJ; Borberg H; Gross R
J Lab Clin Med; 1979 Dec; 94(6):841-7. PubMed ID: 501207
[TBL] [Abstract][Full Text] [Related]
23. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
24. Changes in the molecular size distribution and post-transfusion survival of hydroxyethyl starch 350/0.60 as influenced by a lower degree of hydroxyethylation: a study in normal man.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1980 Sep; 33(9):880-4. PubMed ID: 6159372
[TBL] [Abstract][Full Text] [Related]
25. [Effect of hydroxyethyl starch HES 450/0.7 and 5% human albumin on the colloid osmotic pressure and hemodynamic parameters in hypovolemic patients after major abdominal procedures].
Gahr R; Bock PR
Infusionsther Klin Ernahr; 1981 Jun; 8(3):147-52. PubMed ID: 6167516
[TBL] [Abstract][Full Text] [Related]
26. [Acetyl starch as volume substitute, a possible alternative to HES].
Asskali F; Warnken U; Förster H
Dtsch Med Wochenschr; 2001 Jan; 126(1-2):1-6. PubMed ID: 11200658
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
Hausdörfer J; Hagemann H; Heine J
Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
[TBL] [Abstract][Full Text] [Related]
28. [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].
Landgraf H; Ehrly AM; Saeger-Lorenz K; Vogel C
Infusionsther Klin Ernahr; 1981 Aug; 8(4):200-4. PubMed ID: 6168586
[TBL] [Abstract][Full Text] [Related]
29. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
[TBL] [Abstract][Full Text] [Related]
30. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
Kori-Lindner C; Hubert H
Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
[TBL] [Abstract][Full Text] [Related]
31. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
32. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
33. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
34. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
[TBL] [Abstract][Full Text] [Related]
35. Coagulation disorders caused by hydroxyethyl starch.
Treib J; Haass A; Pindur G
Thromb Haemost; 1997 Sep; 78(3):974-83. PubMed ID: 9308738
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock.
Marx G; Pedder S; Smith L; Swaraj S; Grime S; Stockdale H; Leuwer M
Crit Care Med; 2006 Dec; 34(12):3005-10. PubMed ID: 16971858
[TBL] [Abstract][Full Text] [Related]
37. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
Mishler JM; Dürr HK
Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
39. [Effect of volume replacement with hydroxyethyl starch solution for blood loss on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian carcinoma].
Guo XY; Xu ZH; Ren HZ; Luo AL; Huang YG; Ye TH
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):114-7. PubMed ID: 12812678
[TBL] [Abstract][Full Text] [Related]
40. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
Medel J; Baron JF
Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
